Key advances in ALL and AML

Bookmark and Share
Published: 7 Aug 2018
Views: 1205
Dr Martin S. Tallman - Moffitt Cancer Center, Tampa, USA

Dr Martin Tallman speaks to ecancer at BEST OF ASCO® 2018 MIAMI SYMPOSIUM about acute myeloid leukaemia and acute lymphoblastic leukaemia.

He talks about the high mutation rate, and how this effects treatment.

From this he discusses some of the treatment options and survival rates for these.